Imaging and Radiooncology German Cancer Research Center (DKFZ) in Heidelberg

Overview

Focuses on the development of imaging technologies such as ultrasound (US), magnetic resonance imaging (MRI), computed tomography (CT) and positron emission tomography (PET) to allow better anatomical and functional imaging of the cancer within the patient. Multiparametric imaging is applied in cancer patients to early detect and accurately localize cancer, to assess local and distant spreading and to provide information about the individual biologic behavior. In collaboration with clinical partners and focusing on various tumor entities, the information is used for personalized therapy planning, guidance, monitoring and follow-up in clinical studies and multidisciplinary therapy approaches.

Features

• The Imaging and Radiooncology programme from German Cancer Research Center (DKFZ) in Heidelberg is a unique research program at the DKFZ that performs research from basic science at the biophysical and molecular levels to preclinical research and research in cancer patients involving the imaging and treatment of cancer within own prospective controlled clinical trials.
• In addition to the research effort within FSP-E, there is a strong cooperation between the research scientists at the DKFZ and the clinicians at the University Hospital of Heidelberg and National Center for Tumor Diseases (NCT). Further cooperations exist within the network of the German Cancer Consortium (DKTK). The clinical translational groups within FSP-E allow for novel research discoveries to be rapidly adopted within the clinical hospital environment at the Universities of Heidelberg and Mannheim.